Ultragenyx Pharmaceutical shares owned by Smith Asset Management Group
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Smith Asset Management Group
from 13F filings
Historical chart of Smith Asset Management Group investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Smith Asset Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2021-06-30 | $7.0k | 70 | 100.00 |
| 2021-03-31 | $8.0k | 70 | 114.29 |
| 2020-12-31 | $271k | 2.0k | 138.27 |
| 2020-09-30 | $161k | 2.0k | 82.14 |
| 2020-06-30 | $154k | 2.0k | 78.17 |
| 2020-03-31 | $89k | 2.0k | 44.50 |
| 2019-12-31 | $85k | 2.0k | 42.50 |
| 2019-09-30 | $86k | 2.0k | 43.00 |
| 2019-06-30 | $107k | 1.7k | 63.69 |
| 2019-03-31 | $95k | 1.4k | 69.34 |
| 2018-12-31 | $260k | 6.0k | 43.55 |
| 2018-09-30 | $463k | 6.1k | 76.28 |
| 2018-06-30 | $357k | 4.7k | 76.77 |
| 2018-03-31 | $237k | 4.7k | 50.97 |
| 2017-12-31 | $397k | 8.6k | 46.43 |
| 2017-09-30 | $455k | 8.6k | 53.22 |
| 2017-06-30 | $531k | 8.6k | 62.11 |
| 2017-03-31 | $586k | 8.7k | 67.75 |
| 2016-12-31 | $609k | 8.7k | 70.32 |
| 2016-09-30 | $621k | 8.8k | 70.89 |
| 2016-06-30 | $428k | 8.8k | 48.86 |
| 2016-03-31 | $600k | 9.5k | 63.36 |
| 2015-12-31 | $856k | 7.6k | 112.19 |
More positions owned by Smith Asset Management Group
View all positions for Smith Asset Management Group